Showing results (351-360 of 1,086) with videos related to
Sort By:
Pageof 109
Thrombosis and Haemostasis|December 11, 2012
Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) studyJorge F Saucedo, Dominick J Angiolillo, Roger DeRaad, et al.European Heart Journal. Acute Cardiovascular Care|July 12, 2015
Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplastyAlessandro Lupi, Andrea Rognoni, Chiara Cavallino, et al.Thrombosis Research|July 16, 2014
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER studyJoseph A Jakubowski, Dominick J Angiolillo, Chunmei Zhou, et al.Journal of the American Heart Association|March 31, 2017
Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary InterventionJoseph M Sweeny, Dominick J Angiolillo, Francesco Franchi, et al.Seminars in Thrombosis and Hemostasis|October 12, 2022
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and TreatmentLuis Ortega-Paz, Azita H Talasaz, Parham Sadeghipour, et al.Thrombosis and Haemostasis|March 25, 2016
Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel. Insights from the ELEVATE-TIMI 56 TrialEdward T Carreras, Willibald Hochholzer, Andrew L Frelinger, et al.European Heart Journal. Acute Cardiovascular Care|January 14, 2016
Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionPiera Capranzano, Davide Capodanno, Chiara Bucciarelli-Ducci, et al.BMJ Open Diabetes Research & Care|February 27, 2021
Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover studyFrancesco Franchi, Dmitry M Yaranov, Fabiana Rollini, et al.European Heart Journal. Cardiovascular Pharmacotherapy|September 14, 2021
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trialsLuis Ortega-Paz, Mattia Galli, Davide Capodanno, et al.Journal of Thrombosis and Thrombolysis|August 18, 2019
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence studyDominick J Angiolillo, Deepak L Bhatt, Frank Lanza, et al.Pageof 109